Not recruiting
Relapsing-remitting multiple sclerosis
Not recruitingStudy on the Safety and Effectiveness of Dimethyl Fumarate for Children Aged 10-17 with Relapsing-Remitting Multiple Sclerosis
InvestigationalNo placebo
Study on the Safety and Effectiveness of Dimethyl Fumarate for Children Aged 10-17 with Relapsing-Remitting Multiple Sclerosis
InvestigationalNo placebo
- Disease:Relapsing-remitting multiple sclerosis
- Substances:Dimethyl Fumarate
Countries:
France
France- Participants:0–17 years
- Substances:Dimethyl Fumarate
